Campos, M.T.; Silva, F.A.L.S.; Fernandes, J.R.; Santos, S.G.; Magalhães, F.D.; Oliveira, M.J.; Pinto, A.M.
New MoS2/Tegafur-Containing Pharmaceutical Formulations for Selective LED-Based Skin Cancer Photo-Chemotherapy. Pharmaceutics 2024, 16, 360.
https://doi.org/10.3390/pharmaceutics16030360
AMA Style
Campos MT, Silva FALS, Fernandes JR, Santos SG, Magalhães FD, Oliveira MJ, Pinto AM.
New MoS2/Tegafur-Containing Pharmaceutical Formulations for Selective LED-Based Skin Cancer Photo-Chemotherapy. Pharmaceutics. 2024; 16(3):360.
https://doi.org/10.3390/pharmaceutics16030360
Chicago/Turabian Style
Campos, Miguel T., Filipa A. L. S. Silva, José Ramiro Fernandes, Susana G. Santos, Fernão D. Magalhães, Maria J. Oliveira, and Artur M. Pinto.
2024. "New MoS2/Tegafur-Containing Pharmaceutical Formulations for Selective LED-Based Skin Cancer Photo-Chemotherapy" Pharmaceutics 16, no. 3: 360.
https://doi.org/10.3390/pharmaceutics16030360
APA Style
Campos, M. T., Silva, F. A. L. S., Fernandes, J. R., Santos, S. G., Magalhães, F. D., Oliveira, M. J., & Pinto, A. M.
(2024). New MoS2/Tegafur-Containing Pharmaceutical Formulations for Selective LED-Based Skin Cancer Photo-Chemotherapy. Pharmaceutics, 16(3), 360.
https://doi.org/10.3390/pharmaceutics16030360
